Treatment of recalcitrant discoid lupus erythematosus with roflumilast 0.3% cream following suboptimal response to anifrolumab and improvement of hypopigmentation

JAAD Case Rep. 2024 Oct 9:54:50-52. doi: 10.1016/j.jdcr.2024.09.016. eCollection 2024 Dec.

Authors

Kareena S Garg¹, Leonardo A Tjahjono²

Affiliations

¹ Georgetown University School of Medicine, Washington, District of Columbia.
² Department of Dermatology, School of Medicine and Health Sciences, The George Washington University, Washington, District of Columbia.

No abstract available

Keywords: anifrolumab; autoimmune; discoid lupus erythematosus; phosphodiesterase type 4 inhibitor; roflumilast 0.3% cream.

Publication types

Case Reports